Steve Shen

Dr. Steve Shen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 2024 in ACG Case Reports Journal
Verified
Journal Article
Open access
RLRick Y. Lin
Rick Y. Lin
SSSteve Shen
Steve Shen
PDPatrick L. Donabedian
Patrick L. Donabedian
CKCalvin Kiani
Calvin Kiani
JKJesse Kresak
Jesse Kresak
LDLara Dakhoul
Lara Dakhoul
Bone metastases and a colonic mass in the ascending colon. The biopsy of the mass from colonoscopy demonstrated RCC primary. Although rare, this case report highlights the importance of a thorough evaluation of patients with a history of RCC and considers GI tract involvement in those presenting with GI bleeding....

15 July 2024 in Clinical and Translational Gastroenterology
Verified
Journal Article
Open access
DDDevika Dixit
Devika Dixit
NRNicole C. Ruiz
Nicole C. Ruiz
SSSteve Shen
Steve Shen
ADArvin Daneshmand
Arvin Daneshmand
VRVanessa I. Rodriguez
Vanessa I. Rodriguez
AKAmir Y Kamel
Amir Y Kamel
INTRODUCTION: Crohn's disease and ulcerative colitis are characterized by chronic inflammation of the gastrointestinal tract. Mucosal healing (MH) is a therapeutic goal in patients with inflammatory bowel disease (IBD). Current data suggest that Black patients may experience worse clinical outcomes than White patients with IBD. This study assessed MH between Black and White patients with IBD. METHODS: Retrospective analysis was performed on Black and White adults with IBD who were hospitalized for an active flare. The presence of MH was assessed at 6–18 months after hospitalization. IBD treatments received before and during hospitalization, within 6 months, and 6–18 months after discharge were recorded. C-reactive protein (CRP) levels were collected at hospitalization and 6–18 months after discharge; the difference was reported as delta CRP. RESULTS: One hundred nine patients were followed up after hospitalization. Of those 88 (80.7%) were White patients, and 21 (19.3%) were Black patients. White and Black patients received similar proportions of IBD treatment before (P = 0.2) and during (P = 0.6) hospitalization, within 6 months (P = 0.1), and 6–18 months (P = 0.1) after discharge. Black patients achieved numerically higher rates of MH (15/21 = 71.4% vs 53/88 = 60.2%, P = 0.3) and delta CRP (P = 0.2) than White patients, however, not statistically significant. DISCUSSION: In patients admitted to the hospital with an IBD flare with similar treatment and care, there was a trend toward higher rates of MH in Black patients compared with White patients. These data suggest that MH is likely not the only factor that is associated with Black patients experiencing worse clinical outcomes when compared with White patients.